Chi-squared testing was used to assess clinical relevance, ROC curves were used to estimate diagnostic capability, and overall/relapse-free survival analyses were conducted to examine the impact of LARP4B on patients with liver cancer. The gene discussed is LARP4B; the disease is liver cancer.